NCT07333534

Brief Summary

This randomized controlled study is aimed to evaluate the esthetic, clinical, and radiographic outcomes following the placement of immediate single-tooth implant with hard and soft tissue augmentation. Subjects will randomly assigned to one of two groups:

  • Group A (control group) receiving an immediate single-tooth implant in the esthetic zone with bone augmentation only.
  • Group B (study group) receiving an immediate single-tooth implant in the esthetic zone with bone augmentation and connective tissue graft (CTG). The main questions it aims to answer is: Is there is a significant difference in the esthetic outcome between bone augmentation alone and bone augmentation combined with connective tissue graft after immediate dental implant in the esthetic zone?

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
1mo left

Started Dec 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress72%
Dec 2025Jul 2026

First Submitted

Initial submission to the registry

December 15, 2025

Completed
5 days until next milestone

Study Start

First participant enrolled

December 20, 2025

Completed
23 days until next milestone

First Posted

Study publicly available on registry

January 12, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Last Updated

March 13, 2026

Status Verified

November 1, 2025

Enrollment Period

5 months

First QC Date

December 15, 2025

Last Update Submit

March 12, 2026

Conditions

Keywords

immediate implantmaxillary esthetic zoneCTGjumping gapbone augmentation

Outcome Measures

Primary Outcomes (1)

  • Pink Esthetic Score (PES)

    Seven variables to be scored: mesial papilla, distal papilla, curvature of the facial mucosa, level of the facial mucosa, alveolar process, soft tissue color, and texture of facial gingiva at the implant site. A score of 0, 1, or 2 will be given to each parameter to obtain a final score of 14.

    Pink esthetic score (PES) will be assessed at 6 months postoperatively.

Secondary Outcomes (4)

  • Hard tissue assessment (facial bone thickness)

    6 months postoperatively

  • Patient satisfaction questionnaire

    6 months postoperatively

  • Implant survival rate

    6 months postoperatively

  • Rate of complications

    From the intervention to 6 month postoperatively

Study Arms (2)

Hard tissue augmentation with connective tissue graft

EXPERIMENTAL

Hard tissue augmentation (bone grafting) with additional connective tissue graft (CTG) performed at the same time following immediate dental implant in the esthetic zone

Procedure: Immediate dental implant in the esthetic zone

Hard tissue augmentation

ACTIVE COMPARATOR

Hard tissue augmentation (bone grafting) following immediate dental implant in the esthetic zone.

Procedure: Immediate dental implant in the esthetic zone

Interventions

Placement of immediate dental implant after tooth extraction in the maxillary esthetic zone.

Hard tissue augmentationHard tissue augmentation with connective tissue graft

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with a non-restorable tooth or a remaining root without signs of acute infection in the maxillary esthetic zone.
  • The failing tooth is an incisor, canine or first bicuspid in the maxilla bounded by natural sound teeth.
  • Sufficient bone (\>4 mm) apically and palatally to allow for proper implant positioning with sufficient primary stability (≥35 N cm).
  • Sufficient mesial-distal and interocclusal space for placement of the implant and definitive restoration.

You may not qualify if:

  • Patients with systemic conditions affecting bone healing (e.g., uncontrolled diabetes).
  • Teeth with current acute periapical infection.
  • Dehiscence of the labial (facial) bone plate after extraction.
  • Signs of uncontrolled periodontal disease.
  • Heavy smokers and vulnerable groups (pregnant females and decision-impaired individuals).
  • History of head and neck radiation therapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Baghdad/ College of Dentistry/ Department of Oral and Maxillofacial surgery/ Implant Unit

Baghdad, Rusafa, 10047, Iraq

RECRUITING

Central Study Contacts

Khalid Khalid, Bachelor of Dental Surgery

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 15, 2025

First Posted

January 12, 2026

Study Start

December 20, 2025

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

March 13, 2026

Record last verified: 2025-11

Locations